International Myeloma Foundation (IMF) Celebrates Myeloma Milestones for 2025 Myeloma Action Month
Myeloma Action Month is an annual global awareness campaign that takes place every March to raise awareness and inspire ...
Pharmabiz12h
Kangpu Biopharma receives China NMPA’s IND approval for KPG-818 to treat relapsed/refractory multiple myeloma
Kangpu Biopharma receives China NMPA’s IND approval for KPG-818 to treat relapsed/refractory multiple myeloma: Hefei, China Saturday, March 1, 2025, 14:00 Hrs [IST] Kangpu Bioph ...